Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Skin epithelial cells are the predominant cell type forming the outermost layer of the skin, known as the epidermis[1][3][2]. The primary type of skin epithelial cell is the keratinocyte, which originates in the basal layer, proliferates and differentiates as it migrates outward, and ultimately forms the stratum corneum that creates the physical barrier preventing water loss and entry of pathogens[3][1][2]. Skin epithelial cells possess properties such as polarity, tight junctions, and regenerative capacity, and fulfill essential roles in protection, secretion (in glandular structures), sensation, and repair, contributing critically to immune defenses and tissue homeostasis[1][2][3][5][6]. Although dysregulation of these cells is implicated in diseases such as cancer or inflammatory conditions, “skin epithelial cell” is a generic term and not a molecular or receptor target suitable for direct drug targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skin epithelial cell.